Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report) traded up 21.2% on Thursday . The stock traded as high as C$0.21 and last traded at C$0.20. 292,294 shares changed hands during mid-day trading, a decline of 46% from the average session volume of 538,273 shares. The stock had previously closed at C$0.17.
Voyageur Pharmaceuticals Price Performance
The business has a fifty day moving average of C$0.11 and a 200-day moving average of C$0.08. The company has a current ratio of 0.17, a quick ratio of 0.84 and a debt-to-equity ratio of 3.21. The firm has a market cap of C$25.10 million, a PE ratio of -18.00 and a beta of 0.32.
Voyageur Pharmaceuticals Company Profile
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Recommended Stories
- Five stocks we like better than Voyageur Pharmaceuticals
- Earnings Per Share Calculator: How to Calculate EPS
- ServiceNow Stock Slips, But AI Expansion Signals Long-Term Gains
- How to Short a Stock in 5 Easy Steps
- Microsoft and Meta’s AI Investment Plans Are Full Steam Ahead
- Why Special Dividends Can be a Delightful Surprise for Income Investors
- Beyond Self-Driving Cars: Factory Automation Takes Center Stage
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
